Stockreport

Bionomics Provides a Review of 2023 and of 2024 Plans

Bionomics Limited  (BNOX) 
PDF Positive Phase 2b data announced for BNC210 on reduction of total symptom severity and multiple symptom clusters in post-traumatic stress disorder (PTSD), with a discuss [Read more]